← Back to Dashboard

CIPLA Cipla Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare · Nifty 50 Weight: 0.66%
₹ 1,432.50
-0.63%
1-year price · range ₹1,196–₹1,645

Live setups screens CIPLA is on right now — tap to see every stock matching

Smart Money Verdict synthesis of derivatives, deals, and promoter files

No significant institutional activity detected
Derivative metrics and institutional flows are quiet. No recent bulk deals or insider disclosures have been reported.

Analysis what the data is telling us about CIPLA

In the last completed session, Cipla Ltd. closed +1.63% with futures open interest moving +0.5%. Positioning is neutral — neither side is decisively adding or unwinding right now. The stock's option PCR sits at 0.57, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹1,450 sits 1.2% above the current price, a mild magnet near expiry.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Cipla Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Cipla Ltd. is balanced between accumulation and distribution forces. The next scheduled earnings report is on 2026-07-23, with the consensus EPS estimate at ₹10.423. Earnings days routinely override positioning signals — keep an eye on the calendar.

F&O Positioning EOD derivatives setup

Buildup Class
Neutral
bias: neutral
Futures OI
14,486,550
+70975 (+0.5%)
Option PCR (OI)
0.57
heavy call writing
Max Pain Strike
₹ 1,450
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 1,441.60
yesterday's EOD close
Index Contribution
-0.004 pp
contribution to Nifty
Traded Volume
1,341,452
live shares traded today
Upcoming Earnings
2026-07-23
EPS est: 10.423

Technical Snapshot from 400 sessions of price history

RSI (14)
55.3
neutral momentum
52-Week High
₹ 1,673.00
-13.8% from high
52-Week Low
₹ 1,165.70
+23.7% above low
200-DMA
₹ 1,409.94
+2.2% · above trend
50-DMA
₹ 1,411.04
+2.2% from 50-DMA
1-Year Return
-3.3%
1M +6.6%

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
29.8
price / earnings
P/B
3.4
price / book
ROE
11.7%
return on equity
Market Cap
₹ 115,724 Cr
total market value
Dividend Yield
0.91%
trailing yield
EPS (TTM)
₹ 48.01
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

No institutional bulk or block deals recorded for this stock in the last 30 sessions.

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-07-28 · spot 1,442 · EOD 2026-07-20

Option writers expect range between 1,400 and 1,500+4.0% upside, -2.9% downside.
roughly symmetric
Call OI (writers) Strike Put OI (writers)
17,850 +0k
IV 52% Δ 0.74 θ -2.6 ν 1
1380
62,900 -72k
IV 35% Δ -0.17 θ -1.2 ν 1
7,650
1390
48,450 +8k
IV 35% Δ -0.21 θ -1.4 ν 1
137,700 -6k
IV 37% Δ 0.73 θ -1.9 ν 1
1400 S
506,175 +86k
IV 35% Δ -0.26 θ -1.5 ν 1
38,675 -7k
IV 37% Δ 0.68 θ -2.0 ν 1
1410
63,325 -6k
IV 34% Δ -0.30 θ -1.6 ν 1
87,975 -23k
IV 38% Δ 0.63 θ -2.2 ν 1
1420
207,825 -21k
IV 34% Δ -0.36 θ -1.7 ν 1
119,425 -11k
IV 37% Δ 0.58 θ -2.2 ν 1
1430
141,525 +20k
IV 34% Δ -0.41 θ -1.8 ν 1
294,525 +57k
IV 36% Δ 0.53 θ -2.2 ν 1
1440
158,950 -1k
IV 34% Δ -0.47 θ -1.8 ν 1
344,250 +30k
IV 36% Δ 0.47 θ -2.2 ν 1
1450 MP
209,525 -2k
IV 33% Δ -0.53 θ -1.7 ν 1
498,525 -9k
IV 36% Δ 0.42 θ -2.1 ν 1
1460
260,100 -8k
IV 33% Δ -0.59 θ -1.6 ν 1
480,250 +83k
IV 35% Δ 0.36 θ -2.0 ν 1
1470
204,850 +2k
IV 32% Δ -0.65 θ -1.5 ν 1
351,050 -49k
IV 35% Δ 0.31 θ -1.8 ν 1
1480
165,325 -6k
IV 31% Δ -0.71 θ -1.3 ν 1
116,875 -18k
IV 35% Δ 0.26 θ -1.7 ν 1
1490
187,850 -18k
IV 31% Δ -0.76 θ -1.2 ν 1
1,656,225 -11k
IV 34% Δ 0.22 θ -1.5 ν 1
1500 R
116,025 -9k
IV 32% Δ -0.80 θ -1.0 ν 1

Chain Interpretation

Spot Underlying 1,441.60
Key Resistance (R) 1,500
Key Support (S) 1,400
Max Pain Strike (MP) 1,450
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for CIPLA options · 2026-07-28 expiry

Underlying: CIPLA · Spot: ₹ 1,441.60 · Expiry: 2026-07-28 · Lot: 425

Legs

Side
Type
Strike
Qty
Premium
Net premium
Max profit
Max loss
Breakevens
Position Delta
Position Theta/day
Position Vega/1% IV

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others

CIPLA — frequently asked questions

What is the Cipla Ltd. share price today?

CIPLA is trading at ₹1,432.50 (-0.63% vs previous close), per the latest update on this page.

What is the P/E ratio of Cipla Ltd.?

CIPLA (Cipla Ltd.) has a trailing twelve-month P/E ratio of 29.8.

What is the market cap of Cipla Ltd.?

CIPLA has a market capitalisation of approximately ₹115,724 crore.

What is the ROE of Cipla Ltd.?

CIPLA has a return on equity (ROE) of about 11.7%.

Is CIPLA near its 52-week high?

CIPLA is trading -13.8% from its 52-week high of ₹1,673.00 as of 2026-07-20.

What is the RSI of CIPLA?

The 14-day RSI of CIPLA is 55.3, which is considered neutral.

Is CIPLA above its 200-day moving average?

CIPLA is trading above its 200-DMA of ₹1,409.94 (+2.2% away).

What is the F&O buildup in CIPLA?

The latest end-of-day derivatives data classifies CIPLA as Neutral (bias: neutral), based on the day's combined price and open-interest change.

What is the max pain and PCR for CIPLA options?

CIPLA's option-chain max pain strike is ₹1,450 and its put-call ratio (OI) is 0.57, from the latest end-of-day option chain.

Are FIIs or big investors buying CIPLA?

Strota tracks every bulk and block deal in CIPLA with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.